title: Sulfonates-PMMA nanoparticles conjugates: a versatile system for multimodal application.
abstract: We report herein the viability of a novel nanoparticles (NPs) conjugated system, namely the attachment, based on ionic and hydrophobic interactions, of different sulfonated organic salts to positively charged poly(methylmethacrylate) (PMMA)-based core-shell nanoparticles (EA0) having an high density of ammonium groups on their shells. In this context three different applications of the sulfonates@EA0 systems have been described. In detail, their ability as cytotoxic drugs and pro-drugs carriers was evaluated in vitro on NCI-H460 cell line and in vivo against human ovarian carcinoma IGROV-1 cells. Besides, 8-hydroxypyrene-1,3,6-trisulfonic acid, trisodium salt (HPTS) was chosen for NPs loading, and its internalization as bioimaging probe was evaluated on Hep G2 cells. Overall, the available data support the interest for these PMMA NPs@sulfonates systems as a promising formulation for theranostic applications. In vivo biological data strongly support the potential value of these core-shell NPs as delivery system for negatively charged drugs or biologically active molecules. Additionally, we have demonstrated the ability of these PMMA core-shell nanoparticles to act as efficient carriers of fluorophores. In principle, thanks to the high PMMA NPs external charge density, sequential and very easy post-loading of different sulfonates is achievable, thus allowing the preparation of nanocarriers either with bi-modal drug delivery behaviour or as theranostic systems.
authors.affiliation: Istituto per la Sintesi Organica e la Fotoreattività, CNR-I.S.O.F., Area della Ricerca di Bologna, via P. Gobetti 101, Bologna, Italy.
authors.forename: Claudio
authors.initials: C
authors.lastname: Monasterolo
authors.forename: Marco
authors.initials: M
authors.lastname: Ballestri
authors.forename: Giovanna
authors.initials: G
authors.lastname: Sotgiu
authors.forename: Andrea
authors.initials: A
authors.lastname: Guerrini
authors.forename: Paolo
authors.initials: P
authors.lastname: Dambruoso
authors.forename: Katia
authors.initials: K
authors.lastname: Sparnacci
authors.forename: Michele
authors.initials: M
authors.lastname: Laus
authors.forename: Michelandrea
authors.initials: M
authors.lastname: De Cesare
authors.forename: Assunta
authors.initials: A
authors.lastname: Pistone
authors.forename: Giovanni Luca
authors.initials: GL
authors.lastname: Beretta
authors.forename: Franco
authors.initials: F
authors.lastname: Zunino
authors.forename: Valentina
authors.initials: V
authors.lastname: Benfenati
authors.forename: Greta
authors.initials: G
authors.lastname: Varchi
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry* / Q000627:therapeutic use / Q000633:toxicity; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D004337:Drug Carriers / Q000737:chemistry; D005260:Female; D056945:Hep G2 Cells; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D053758:Nanoparticles / Q000737:chemistry*; D010051:Ovarian Neoplasms / Q000188:drug therapy; D017239:Paclitaxel / Q000008:administration & dosage / Q000737:chemistry; D019904:Polymethyl Methacrylate / Q000737:chemistry*; D011355:Prodrugs / Q000737:chemistry; D013451:Sulfonic Acids / Q000737:chemistry*; D014183:Transplantation, Heterologous
chemical_list: D000970:Antineoplastic Agents; D004337:Drug Carriers; D011355:Prodrugs; D013451:Sulfonic Acids; D019904:Polymethyl Methacrylate; D017239:Paclitaxel